Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nikhil J Pandya

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Nucleic Acids Research|August 30, 2025
Angelman syndrome patient-derived neuron screen leads to clinical ASO rugonersen targeting UBE3A-ATS with long-lasting effect in monkeysRavi Jagasia, Charlotte Bon, Soren V Rasmussen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersJulie Lee, Balazs Toth, Sandra Sanabria Bohorquez, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 8, 2020
Inducers of the endothelial cell barrier identified through chemogenomic screening in genome-edited hPSC-endothelial cellsFilip Roudnicky, Jitao David Zhang, Bo Kyoung Kim, et al.
Molecular Therapy. Nucleic Acids|September 12, 2022
Identification and characterization of a MAPT-targeting locked nucleic acid antisense oligonucleotide therapeutic for tauopathiesAmy Easton, Marianne L Jensen, Congwei Wang, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 1, 2024
Primate cerebrospinal fluid CHI3L1 reflects brain TREM2 agonismStephen P Schauer, Chang Hoon Cho, Gloriia Novikova, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Nucleic Acids Research|August 30, 2025
Angelman syndrome patient-derived neuron screen leads to clinical ASO rugonersen targeting UBE3A-ATS with long-lasting effect in monkeysRavi Jagasia, Charlotte Bon, Soren V Rasmussen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersJulie Lee, Balazs Toth, Sandra Sanabria Bohorquez, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 8, 2020
Inducers of the endothelial cell barrier identified through chemogenomic screening in genome-edited hPSC-endothelial cellsFilip Roudnicky, Jitao David Zhang, Bo Kyoung Kim, et al.
Molecular Therapy. Nucleic Acids|September 12, 2022
Identification and characterization of a MAPT-targeting locked nucleic acid antisense oligonucleotide therapeutic for tauopathiesAmy Easton, Marianne L Jensen, Congwei Wang, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 1, 2024
Primate cerebrospinal fluid CHI3L1 reflects brain TREM2 agonismStephen P Schauer, Chang Hoon Cho, Gloriia Novikova, et al.
Pageof 2